Physician

Steven E Caplan, MD

According to 2025 Medicare claims, Steven Caplan, MD (NPI: 1376516914) practices dermatology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES OF YORK INC (NPI: 1245204023; TIN: 232143100) and primary practice location at 17402-4643.

Caplan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,264 traditional Medicare patients, billed 5,868 HCPCS/CPT codes, and received $353,769 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 769 prescription claims across 419 beneficiaries totaling $299,646 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 33 records totaling $590. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $214,870 to $299,646. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$236K$473K2015 Medicare payment: $437,090 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $433,218 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $416,532 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $440,130 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $472,558 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $403,996 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $370,678 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $354,972 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $346,177 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $353,769 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,4837,213$437,090
20161,4997,368$433,218
20171,4166,819$416,532
20181,4467,150$440,130
20191,6457,997$472,558
20201,4656,699$403,996
20211,2836,138$370,678
20221,2085,926$354,972
20231,2235,472$346,177
20241,2645,868$353,769

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$193K$387K2015 Drug cost: $214,870 (USD; Tot_Drug_Cst)2016 Drug cost: $179,980 (USD; Tot_Drug_Cst)2017 Drug cost: $187,305 (USD; Tot_Drug_Cst)2018 Drug cost: $200,016 (USD; Tot_Drug_Cst)2019 Drug cost: $291,726 (USD; Tot_Drug_Cst)2020 Drug cost: $121,599 (USD; Tot_Drug_Cst)2021 Drug cost: $276,534 (USD; Tot_Drug_Cst)2022 Drug cost: $386,580 (USD; Tot_Drug_Cst)2023 Drug cost: $329,718 (USD; Tot_Drug_Cst)2024 Drug cost: $299,646 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015410804$214,870
2016390742$179,980
2017329660$187,305
2018366660$200,016
2019392726$291,726
2020414808$121,599
2021368782$276,534
2022357703$386,580
2023357675$329,718
2024419769$299,646

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more251307$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more663829$61
17000Destruction of precancer skin growth, 1 growth405460$43
88305Pathology examination of tissue using a microscope, intermediate complexity257394$27
17003Destruction of precancer skin growth, 2-14 growths2981,803$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab13364$48,647
FluorouracilFluorouracil722,051$5,171
Clobetasol PropionateClobetasol Propionate501,526$2,355
TacrolimusTacrolimus21585$2,247
MetronidazoleMetronidazole28807$1,480

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$590ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Steven E. Caplan, MD?

Tedicare shows public-source Medicare data for Steven E. Caplan, MD (NPI 1376516914), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven E. Caplan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven E. Caplan, MD?

Steven E. Caplan, MD is linked to DERMATOLOGY ASSOCIATES OF YORK INC (billing NPI 1245204023) in the available physician profile data.

Does Steven E. Caplan, MD have Open Payments data?

Steven E. Caplan, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.